Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News 60 Degrees Pharmaceuticals Inc SXTP

Alternate Symbol(s):  SXTPW

Healthcare Biotechnology
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria preventative treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:SXTP)

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

GlobeNewswire 2 days ago

60 Degrees Pharmaceuticals Announces Clinical Site Now Open for Patient Enrollment for the B-FREE Chronic Babesiosis Study at Mount Sinai Icahn School of Medicine

GlobeNewswire November 21, 2025

60 Degrees Pharmaceuticals Announces Third Quarter 2025 Results

GlobeNewswire November 13, 2025

60 Degrees Pharmaceuticals Announces No Detection of Babesia Infection in First Patient Following Treatment with Tafenoquine in Relapsing Babesiosis Study

GlobeNewswire October 15, 2025

60 Degrees Pharmaceuticals Unveils Name of Chronic Babesiosis Clinical Trial: B-FREE Chronic Babesiosis Study

GlobeNewswire October 9, 2025

60 Degrees Pharmaceuticals Live Webcast Link and New Date for Presentation at H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire September 3, 2025

60 Degrees Pharmaceuticals to Present at H.C. Wainwright 27th Annual Global Investment Conference

GlobeNewswire August 21, 2025

60 Degrees Pharmaceuticals Selects Icahn School of Medicine at Mount Sinai as Central Clinical Trial Site for Phase II Study to Evaluate Tafenoquine for Chronic Babesiosis

GlobeNewswire August 19, 2025

60 Degrees Pharmaceuticals Announces Second Quarter 2025 Results

GlobeNewswire August 13, 2025
View More News ››

Opinion & Analysis (NDAQ:SXTP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:SXTP)

Buy buddy buy.

From the day trading establishment.
coolfooldumbguy - January 8, 2025

BUY BUY BUY BUY BUY

About to blow the lid off the top
Nibinator - July 25, 2024

RE:RE:SXTP....early a.m runner up on no News

Dang ....forgot to post the NR....   60 Degrees Pharmaceuticals Signs Clinical Trial Agreements With All Planned Trial...
Iseneschal - July 19, 2024

RE:SXTP....early a.m runner up on no News

Excuse me.....there was a NR at 5:30....just as I was posting my last post. Regardless.......fluff news......Ya pays yo money and yo...
Iseneschal - July 19, 2024

SXTP....early a.m runner up on no News

The Market Maker is calling all the Retail Chasers to get on board.....because he has lots of paer to flog to them at inflated prices...
Iseneschal - July 19, 2024

SXTP....Thru RBL....next support at 92 cents

Just in case your wondering
Iseneschal - December 21, 2023
View more Bullboard ››

Nurcapital Capital Pool

Nurcapital Capital Pool

Nurcapital Corporation Ltd. is a Canada-based capital pool company. The Company is engaged in identifying and evaluating ...
View More »